Active, not recruitingNot applicableNCT02051088

Swedish Drug-elution Trial in Peripheral Arterial Disease

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sahlgrenska University Hospital
Principal Investigator
Mårten Falkenberg, MD, PhD
Department of Radiology, Sahlgrenska University Hospital
Intervention
Revascularization with drug-eluting technology(procedure)
Enrollment
3556 enrolled
Eligibility
18 years · All sexes
Timeline
20142026

Study locations (1)

Collaborators

The Swedish Research Council · Swedish Heart Lung Foundation · Uppsala University · The Swedish National Registry for Vascular Surgery

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02051088 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials